PEAK6 Investments’s Novartis NVS Stock Holding History

PEAK6 Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,600	Closed	-$423K	–	4456
2023 Q1	$423K	Sell	4,600 -85,100	-95%	-$7.43M	﹤0.01%	2531
2022 Q4	$8.14M	Buy	89,700 +85,000	+1,809%	+$7.16M	0.05%	461
2022 Q3	$357K	Buy	+4,700	New	+$390K	﹤0.01%	3188
2021 Q4	–	Sell	-2,400	Closed	-$196K	–	5601
2021 Q3	$196K	Sell	2,400 -49,300	-95%	-$4.44M	﹤0.01%	4003
2021 Q2	$4.72M	Sell	51,700 -28,100	-35%	-$2.5M	0.01%	1159
2021 Q1	$6.82M	Sell	79,800 -50,700	-39%	-$4.55M	0.02%	850
2020 Q4	$12.3M	Buy	130,500 +124,700	+2,150%	+$10.9M	0.03%	578
2020 Q3	$504K	Sell	5,800 -117,900	-95%	-$10.2M	﹤0.01%	2846
2020 Q2	$10.8M	Buy	123,700 +88,800	+254%	+$7.67M	0.04%	459
2020 Q1	$2.88M	Buy	34,900 +11,700	+50%	+$1.04M	0.02%	806
2019 Q4	$2.2M	Sell	23,200 -100,551	-81%	-$9.02M	0.01%	1032
2019 Q3	$10.8M	Buy	123,751 +45,651	+58%	+$4.1M	0.07%	330
2019 Q2	$7.13M	Buy	78,100 +19,398	+33%	+$1.64M	0.05%	512
2019 Q1	$5.06M	Buy	58,702 +35,378	+152%	+$2.84M	0.03%	704
2018 Q4	$1.79M	Sell	23,324 -72,875	-76%	-$5.67M	0.01%	1315
2018 Q3	$7.43M	Buy	+96,199	New	+$7.11M	0.03%	592

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PEAK6 Investments's NVS Position: Q4 2022 in Review

PEAK6 Investments sold out of Novartis (NVS) in Q4 2022, closing a stake of 17,868 shares — an estimated $1.5M sold.

PEAK6 Investments first reported a position in NVS in Q4 2018 and held it in 6 quarters. The position peaked at $4.31M in Q4 2018. 1,183 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

PEAK6 Investments reported no remaining Novartis position as of Q4 2022 after selling out during the quarter.
PEAK6 Investments sold 17,868 Novartis shares in Q4 2022, an estimated $1.5M.
PEAK6 Investments first reported a position in Novartis in Q4 2018 and held it in 6 quarters.
PEAK6 Investments's Novartis position peaked at $4.31M in Q4 2018.
1,183 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.